Outpost’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Outpost is a biopharmaceutical company that focuses on the development of therapeutics for the treatment of urologic and gynecologic disorders. Read more

Outpost is a biopharmaceutical company that focuses on the development of therapeutics for the treatment of urologic and gynecologic disorders. Read more

Scott Byrd's photo - President & CEO of Outpost

President & CEO

Scott Byrd

CEO Approval Rating

79/100

Founded:

2016

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Synergy Pharmaceuticals has been one of Outpost's top competitors. Synergy Pharmaceuticals's headquarters is in New York, New York, and was founded in 2005. Synergy Pharmaceuticals is in the Pharmaceuticals industry. Synergy Pharmaceuticals generates 2,067% of Outpost's revenue.

Ironwood Pharmaceuticals Inc is one of Outpost's top rivals. Ironwood Pharmaceuticals Inc is a Public company that was founded in Boston, Massachusetts in 1998. Ironwood Pharmaceuticals Inc operates in the Pharmaceuticals industry. Ironwood Pharmaceuticals Inc has 302 more employees vs. Outpost.

Sucampo is perceived as one of Outpost's biggest rivals. Sucampo was founded in 1996, and is headquartered in Rockville, Maryland. Like Outpost, Sucampo also works within the Biotechnology industry. Sucampo generates $248.5M more revenue vs. Outpost.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 15 a good estimate for Outpost's Employee count?

Acquisitions

No recent acquisitions found related to Outpost

Outpost Funding History

$15.5M$91.5M

Since Outpost was founded in 2016, it has participated in 3 rounds of funding. In total Outpost has raised $91.5M. Outpost's last funding round was on Nov 2017 for a total of $20.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Nov 2017
$20M
Equity
May 2017
$56M
-
Equity
Mar 2016
$15.5M
-

Total Funding: $91.5M

Since Outpost was founded in 2016, it has participated in 3 rounds of funding. In total Outpost has raised $91.5M. Outpost's last funding round was on Nov 2017 for a total of $20.0M

Investments

No recent investments found related to Outpost

Outpost News

November 16, 2017Inside INdiana Business

Funding Commitment Grows For Indy-Connected Biopharma Company

A biopharmaceutical company with offices in Indianapolis and London has announced a $20 million boost... See more »
July 18, 2016BioSpace

Outpost Medicine Expands Senior Leadership Team

Life Sciences Jobs ...... See more »

Outpost Press Releases

Headquarters

10401 N. Meridian Street Suite 225

Indianapolis, Indiana46290

317-740-0670

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Outpost is a biopharmaceutical company that focuses on the development of therapeutics for the treatment of urologic and gynecologic disorders. Outpost was founded in 2016. Outpost's headquarters is located in Indianapolis, Indiana, USA 46290. It has ...

CEO

Outpost's President & CEO, Scott Byrd, currently has an approval rating of 79%. Outpost's primary competitors are Synergy Pharmaceuticals, Ironwood Pharmaceuticals Inc & Sucampo.

Website

outpostmedicine.com

Frequently Asked Questions about Outpost

  1. When was Outpost founded?

    Outpost was founded in 2016
  2. Who is Outpost's CEO?

    Outpost's CEO is Scott Byrd
  3. How much revenue does Outpost generate?

    Outpost generates $2M in revenue
  4. How much funding does Outpost have?

    Outpost has historically raised $91.5M in funding
  1. Where is Outpost's headquarters?

    Outpost's headquarters is in Indianapolis Indiana, USA
  2. How many employees does Outpost have?

    Outpost has 15 employees
  3. What sector does Outpost operate in?

    Outpost is in Biotechnology
  4. Who are Outpost's competitors?

    Outpost's top competitors are Synergy Pharmaceuticals, Ironwood Pharmaceuticals Inc, Sucampo